[go: up one dir, main page]

WO2009005155A1 - 間葉系幹細胞の増殖能・分化能維持方法 - Google Patents

間葉系幹細胞の増殖能・分化能維持方法 Download PDF

Info

Publication number
WO2009005155A1
WO2009005155A1 PCT/JP2008/062239 JP2008062239W WO2009005155A1 WO 2009005155 A1 WO2009005155 A1 WO 2009005155A1 JP 2008062239 W JP2008062239 W JP 2008062239W WO 2009005155 A1 WO2009005155 A1 WO 2009005155A1
Authority
WO
WIPO (PCT)
Prior art keywords
msc
differentiation ability
proliferation
stem cell
mesenchymal stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/062239
Other languages
English (en)
French (fr)
Inventor
Masahiro Go
Chiemi Takenaka
Hajime Ohgushi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STEM CELL SCIENCES KK
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
STEM CELL SCIENCES KK
National Institute of Advanced Industrial Science and Technology AIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STEM CELL SCIENCES KK, National Institute of Advanced Industrial Science and Technology AIST filed Critical STEM CELL SCIENCES KK
Publication of WO2009005155A1 publication Critical patent/WO2009005155A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073Stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0663Bone marrow mesenchymal stem cells (BM-MSC)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60Transcription factors
    • C12N2501/602Sox-2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60Transcription factors
    • C12N2501/605Nanog

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

【課題】ヒト成人骨髄由来MSCの増殖能・分化能を維持する方法、或いは増殖能・分化能を維持した間葉系幹細胞、さらには間葉系幹細胞に作用する薬物のスクリーニング方法を開発することを目的とし、間葉系幹細胞(MSC)、特にヒト成人骨髄由来MSCの増殖能・分化能を維持する。 【解決手段】間葉系幹細胞(MSC)、特にヒト成人骨髄由来MSCの増殖能・分化能を維持する方法を提供する。Sox2あるいはNanog遺伝子を導入することで強制的・安定的に遺伝子発現を誘導すること、あるいはSox2遺伝子を導入することと成長因子であるbFGFの培地への添加を併用することにより、MSCの増殖能・分化能を維持することができる。
PCT/JP2008/062239 2007-07-05 2008-07-05 間葉系幹細胞の増殖能・分化能維持方法 Ceased WO2009005155A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007177767A JP2009011254A (ja) 2007-07-05 2007-07-05 間葉系幹細胞の増殖能・分化能維持方法
JP2007-177767 2007-07-05

Publications (1)

Publication Number Publication Date
WO2009005155A1 true WO2009005155A1 (ja) 2009-01-08

Family

ID=40226193

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/062239 Ceased WO2009005155A1 (ja) 2007-07-05 2008-07-05 間葉系幹細胞の増殖能・分化能維持方法

Country Status (2)

Country Link
JP (1) JP2009011254A (ja)
WO (1) WO2009005155A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108603167A (zh) * 2015-09-15 2018-09-28 思特科技公司 使用其中引入nanog的源自羊水胎儿的间充质干细胞制备用于促进毛发生长的组合物的方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018131900A2 (ko) * 2017-01-11 2018-07-19 주식회사 스템랩 나노그를 도입한 양수 내 태아 유래 중간엽 줄기세포로부터 획득한 엑소좀 내 포함된 육모 촉진용 조성물의 제조방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005110565A (ja) * 2003-10-07 2005-04-28 Nobuya Yamanaka 分化多能性維持剤
WO2007010858A1 (ja) * 2005-07-15 2007-01-25 Kyoto University 骨格筋組織由来の単一細胞よりクローン化した多能性幹細胞

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005110565A (ja) * 2003-10-07 2005-04-28 Nobuya Yamanaka 分化多能性維持剤
WO2007010858A1 (ja) * 2005-07-15 2007-01-25 Kyoto University 骨格筋組織由来の単一細胞よりクローン化した多能性幹細胞

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BOYER L.A. ET AL.: "Core transcriptional regulatory circuitry in human embryonic stem cells", CELL, vol. 122, no. 6, 2005, pages 947 - 956, XP002412923 *
GO M.J. ET AL.: "Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities", EXP. CELL RES., vol. 314, no. 5, pages 1147 - 1154, XP022493853 *
GUILLOT P.V. ET AL.: "Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC", STEM CELLS, vol. 25, no. 3, pages 646 - 654 *
ILANCHERAN S. ET AL.: "Stem cells derived from human fetal membranes display multilineage differentiation potential", BIOL. REPROD., vol. 77, no. 3, pages 577 - 588 *
LOH Y.H. ET AL.: "The Oct4 and Nanog transcription network regulation pluripotency in mouse embryonic stem cells", NAT. GENET., vol. 38, no. 4, 2006, pages 431 - 440 *
OGUSHI H.: "Hone Saisei o Mezashita Kan'yokei Kansaibo no Fukatsuka Gijutsu -Hito Kan'yokei Donyu-", INFLAMM. REGEN., vol. 28, no. 4, 1 July 2008 (2008-07-01), pages 290 + ABSTR. NO. S4-6 *
WANG J. ET AL.: "A protein interaction network for pluripotency of embryonic stem cells", NATURE, vol. 444, no. 7117, 2006, pages 364 - 368 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108603167A (zh) * 2015-09-15 2018-09-28 思特科技公司 使用其中引入nanog的源自羊水胎儿的间充质干细胞制备用于促进毛发生长的组合物的方法
US20180362606A1 (en) * 2015-09-15 2018-12-20 Stemlab Inc. Method for preparing composition for promoting hair growth using nanog-introduced mesenchymal stem cells derived from fetus in amniotic fluid
US10640541B2 (en) * 2015-09-15 2020-05-05 Stemlab Inc. Method for preparing composition for promoting hair growth using Nanog-introduced mesenchymal stem cells derived from fetus in amniotic fluid
CN108603167B (zh) * 2015-09-15 2022-01-21 思特科技公司 使用nanog引入的源自羊水胎儿的间充质干细胞制备用于促进毛发生长的组合物的方法

Also Published As

Publication number Publication date
JP2009011254A (ja) 2009-01-22

Similar Documents

Publication Publication Date Title
Gaspar et al. Progress in cell-based therapies for tendon repair
EP4368701A3 (en) Feeder-free culture system
WO2008129563A3 (en) Human mesenchymal stem cells and preparation thereof
WO2010147395A3 (en) Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
WO2006070370A3 (en) Stem cells culture systems
WO2012008813A3 (ko) 양막유래 중간엽 줄기세포 배양을 위한 배지조성물 및 이를 이용한 양막유래 중간엽 줄기세포의 배양방법
WO2010090513A3 (en) Culture medium for epithelial stem cells and organoids comprising said stem cells.
GB2454386A (en) Method for stem cell culture and cells derived therefrom
IL252607B (en) Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
NZ592622A (en) Stem cell aggregate suspension compositions and methods for differentiation thereof
WO2011114237A3 (en) Composition and method for enabling proliferation of pluripotent human stem cells
MX352337B (es) Factor de reprogramacion nuclear.
WO2012032521A8 (en) Novel methods and culture media for culturing pluripotent stem cells
WO2009077134A3 (en) Use of rna for reprogramming somatic cells
WO2007016566A3 (en) Production of reprogrammed cells with restored potential
WO2010033088A8 (en) Method of improving differentiation of chondrogenic progenitor cells
DK2274419T3 (da) Fremgangsmåder til fremstilling af hårmikrofollikler og de novopapiller og anvendelse heraf til in vitro-test og in vivo-implantationer
MY146352A (en) Adipose derived adult stem cells in hepatic regeneration
WO2011025179A3 (en) Method of inducing the differentiation of human embryonic stem cells into mesenchymal stem cells
WO2012141471A3 (ko) 역분화-증진제를 이용한 역분화 만능 줄기세포의 제조방법
WO2011024070A3 (en) Composition and method for proliferating undifferentiated stem cells
WO2011137540A8 (en) Gfi1b modulation and uses thereof
WO2011105821A3 (ko) 무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법
WO2007016366A3 (en) Defined culture conditions of human embryonic stem cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08790919

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08790919

Country of ref document: EP

Kind code of ref document: A1